BIOMAT Database Logo BIOMAT Database Logo

Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651. 1977

W H Beggs, and F A Andrews, and G A Sarosi

UI MeSH Term Description Entries
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005437 Flucytosine A fluorinated cytosine analog that is used as an antifungal agent. 5-Fluorocytosine,Alcobon,Ancobon,Ancotil
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

W H Beggs, and F A Andrews, and G A Sarosi
Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
January 1982, Chemotherapy,
W H Beggs, and F A Andrews, and G A Sarosi
[Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
January 1979, Revista do Instituto de Medicina Tropical de Sao Paulo,
W H Beggs, and F A Andrews, and G A Sarosi
Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
July 1974, The Journal of infectious diseases,
W H Beggs, and F A Andrews, and G A Sarosi
The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
November 1977, The Medical journal of Australia,
W H Beggs, and F A Andrews, and G A Sarosi
Letter: Amphotericin B and 5-fluorocytosine.
October 1975, The Journal of infectious diseases,
W H Beggs, and F A Andrews, and G A Sarosi
Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.
September 1973, Antimicrobial agents and chemotherapy,
W H Beggs, and F A Andrews, and G A Sarosi
[Combination of amphotericin B and 5-fluorocytosine].
May 1978, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W H Beggs, and F A Andrews, and G A Sarosi
Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.
November 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
W H Beggs, and F A Andrews, and G A Sarosi
Peritoneal clearance of amphotericin B and 5-fluorocytosine.
August 1980, The Western journal of medicine,
W H Beggs, and F A Andrews, and G A Sarosi
Synergism of amphotericin B and 5-fluorocytosine for candida species.
July 1975, The Journal of infectious diseases,
Copied contents to your clipboard!